---
$id: https://graph.org.ai/products/commodity/51171959
$type: Product
source: UNSPSC
code: "51171959"
title: "Proxazole"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Proxazole

**UNSPSC Code**: 51171959
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C17H25N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FD72T13M0K, chemically known as 1,2,4-oxadiazole-5-ethanamine, n,n-diethyl-3-(1-phenylpropyl)-, (+)- (9ci) but generally known as proxazole, which bears US NIH Compound Identifier 8590. European Medicines Agency schedules Proxazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10146MIG. The term PROXAZOLE is an International Non-Proprietary Name. World Health Organization schedules proxazole in its Anatomical Therapeutic Chemical (ATC) Classification. PROXAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule proxazole under HS 29349990 and SITC 51579. As of Q4 2014, PROXAZOLE remains the US FDA Preferred Term for this commodity. Proxazole bears US NLM identifiers UMLS ID C0072507 and NCI Concept Code C74176. SMILES: O1NC(NC1CCN(CC)CC)C(CC)C1CCCCC1.

